CXCR4 and CXCR7 transduce through mTOR in human renal cancer cells

Treatment of metastatic renal cell carcinoma (mRCC) has improved significantly with the advent of agents targeting the mTOR pathway, such as temsirolimus and everolimus. However, their efficacy is thought to be limited by feedback loops and crosstalk with other pathways leading to the development of...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Ieranò, C, Santagata, S, Napolitano, M, Guardia, F, Grimaldi, A, Antignani, E, Botti, G, Consales, C, Riccio, A, Nanayakkara, M, Barone, M V, Caraglia, M, Scala, S
פורמט: Artigo
שפה:Inglês
יצא לאור: Nature Publishing Group 2014
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4123065/
https://ncbi.nlm.nih.gov/pubmed/24991762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddis.2014.269
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים